LANSING, Mich. (Michigan News Source) – The state of Michigan’s settlement with numerous drug companies over the opioid epidemic will bring about $1.6 billion to municipalities by 2040, according to the state.
At its last city council meeting, the city of Lansing discussed an estimated $119,871 it would received from just one settlement. That’s the city’s estimated take from a $99.5 million settlement Sandoz Inc. made recently.
MORE NEWS: Trash Talk: Senate Moves to Hike Dumping Fees, Curb Hazardous Waste
Other settlements from drug companies benefitting municipalities in this state that were announced in July include:
- Alvogen:$18.6M
- Amneal Pharmaceuticals: $71.7M (over 10 years)
- Apotex Inc.: $63.6M
- Hikma Pharmaceuticals: $95.8M (up to four years)
- Indivior Inc.: $38.0M (up to four years)
- Mylan Pharmaceuticals: $284.4M (over nine years)
- Sun Pharmaceutical Industries: $30.9M (up to four years)
- Zydus Pharmaceuticals: $14.8M
The state said 50% of the settlement money will be given to county, city and township governments. The other 50% will go to The Michigan Opioid Healing and Recovery Fund.
These settlements are part of continuing legal action that began in 2017 when state and local governments across the country filed thousands of lawsuits against companies involved in the opioid supply chain. These lawsuits alleged these companies engaged in misleading promotion and/or inadequate control of prescription opioids and fueled the opioid pandemic.